Register to chat with like-minded investors on our interactive forums.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Novartis AG | NYSE:NVS | NYSE | Depository Receipt |
| Price Change | % Change | Price | Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.33 | 0.32% | 103.42 | 8,095 | 12:04:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 11:45:24 | 57 | 103.38 | USD |
| Date | Time | Source | Headline |
|---|---|---|---|
| 03/10/2024 | 12:45 | IHNW | Beyond the Horizon: Innovative Drug Combinations Offer New Hope for.. |
| 22/1/2024 | 06:59 | DJN | Sandoz to Acquire Cimerli Business from Coherus for $170 Million |
| 11/1/2024 | 18:02 | DJN | Cytokinetics Shares Slide as Novartis Reportedly Shies Away From Deal |
| 08/1/2024 | 18:43 | DJN | Cytokinetics Shares Jump 16% After WSJ Report of Novartis Deal |
| 08/1/2024 | 15:41 | DJN | Novartis on Track for Record High Close -- Data Talk |
| 08/1/2024 | 07:01 | DJN | Novartis's Scemblix Drug Meets Main Goals in Late-Stage Leukemia Trial |
| 05/1/2024 | 15:15 | DJN | Novartis to Make Pluvicto Radioligand Therapy at Indianapolis Plant |
| 02/1/2024 | 12:46 | DJN | Voyager Therapeutics Shares Leap Premarket on Novartis Collaboration |
| 11/12/2023 | 07:02 | DJN | Novartis Drug Meets Primary Goal in Late-Stage Study for Kidney Disease |
| 06/12/2023 | 10:14 | DJN | Merck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage Trials |
Novartis (NVS) Charts1 Year Novartis Chart |
|
1 Month Novartis Chart |
Intraday Novartis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
